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early 21st centuryO. Murillo1, I. Grau1, J. Lora-Tamayo1, J. Gomez-Junyent1, A. Ribera1, F. Tubau2, J. Ariza1 and R. Pallares1
1) Infectious Disease Service and 2) Microbiology Department, Hospital Universitari de Bellvitge, Barcelona, SpainAbstractOsteoarticular infections (OAI), which are often associated with bacteraemia, seem to be increasing. We studied all patients with bacteraemia
and concomitant OAI: septic arthritis (SA), vertebral osteomyelitis (VOM) or peripheral osteomyelitis (POM), which were seen at our
institution (1985–2011). Data were extracted from a prospective protocol of bacteraemia cases recorded. Trends in main ﬁndings were
considered in ﬁve periods. Major antibiotic resistance patterns were studied. A total of 601 cases of bacteraemic OAI, accounting for
1.8% of total bactaeremias, were studied: SA (48%), VOM (40%) and POM (17%). When comparing the 1985–91 and 2007–11 periods,
the incidence of bacteraemic OAI increased from 2.34 to 5.78 episodes/100 000 inhabitants per year (p <0.001); and nosocomial and
healthcare-related cases increased from 18% to 30% (p <0.001) and from 10% to 25% (p <0.001), respectively. Also, there was an
increase of age (median, from 49 to 65 years, p <0.001), patients with comorbidities (23% to 59%, p <0.001), and device-related OAI
(7% to 28%, p <0.001). Patterns of OAI were changing over time. Compared with younger patients, older adults ( 65 years) had more
VOM, prosthetic-joint infections and enterococcal OAI. The percentage of OAI caused by methicillin-susceptible Staphylococcus aureus
decreased, while those caused by methicillin-resistant S. aureus, streptococci, enterococci, and Gram-negative bacilli increased. There was
a link between certain microorganisms with speciﬁc OAI and age of patients. Over the past three decades, bacteraemic OAI increased in
association with aging and use of orthopaedic devices. Nosocomial and healthcare-related OAI increased, with a rise in multidrug-
resistant bacteria. These trends should be considered when planning diagnostic and therapeutic guidelines for OAI.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Keywords: Bacteraemia, epidemiology, osteoarticular infections, osteomyelitis, septic arthritis, spondylodiscitis
Original Submission: 29 April 2014; Revised Submission: 1 September 2014; Accepted: 11 September 2014
Editor: D. Raoult
Article published online: 12 October 2014Clin
Cli
httCorresponding author: O. Murillo, Infectious Disease Service,
Hospital Universitari de Bellvitge, Feixa Llarga s/n, 08907 L’Hospitalet,
Barcelona, Spain
E-mail: omurillo@bellvitgehospital.catIntroductionOsteoarticular infections (OAI) are often associated with bac-
teraemia with a variable risk depending on the type of infection,
this being higher in native joint and vertebral osteomyelitis than
in prosthetic joint or peripheral osteomyelitis. In any case,Microbiol Infect 2015; 21: 254.e1–254.e8
nical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2014.09.007bacteraemia may occur as a complication of the OAI itself or
secondary to a distant infection [1–4].
Little is known about changes in epidemiological and clinical
ﬁndings of OAI over long periods of time. Conceivably, there
may have been major changes in the microbiology, types of OAI
and the characteristics of patients at risk. For example, the
widespread use of medical devices in orthopaedic surgery and
increased life expectancy of the population are all factors
related to the increased rates of some OAI [5–8]. Also, the
emergence of multidrug-resistant microorganisms (e.g.
methicillin-resistant Staphylococcus aureus, MRSA) in hospitals
and other healthcare institutions has been associated with
increased rates of bacteraemic infections caused by difﬁcult-to-
treat pathogens [9–11]. Lastly, an increasing incidence ofious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Murillo et al. Epidemiology of osteoarticular infection 254.e2infections has been related to the improvement of identiﬁcation
methods of microorganism [12,13].
In the present study we analysed a large cohort of patients
with bacteraemic OAI who attended at our institution over the
past three decades. The main objectives were to determine
changes over time in the types and characteristics of OAI, the
microorganisms causing these infections, associated comor-
bidities and other patient characteristics.Patients and methodsThis study was carried out in Bellvitge hospital, a 700-bed
teaching institution in Barcelona, Spain. The hospital does not
attend paediatric, obstetric or burns patients. It has a Bone and
Joint Infection Unit, run by a multidisciplinary medical team.
Over the past three decades, information of all patients with
bloodstream infections has been collected in a prospective
database, including data on patients’ baseline characteristics,
clinical presentation and source of bacteraemia, and microbi-
ological records.Patient’s characteristics and deﬁnitionsAll patients with OAI and bacteraemia who attended at our
institution from 1985 to 2011 were analysed. This included
both patients with an osteoarticular focus as the source of
bacteraemia (‘primary’ bacteraemic OAI) and patients with
bacteraemia from a distant focus, in whom the osteoarticular
infection was the result of a septic metastasis (‘secondary’
bacteraemic OAI).
Blood samples were cultured following standard recom-
mendations by the automated BacTEC method with both aer-
obic and anaerobic media (systems used were as follows: in the
1990s Bactec NR-860, in 2000s Bactec 9240, and in 2010s
Bactec FX; Becton-Dickinson Microbiology Systems, Franklin
Lakes, NJ, USA). During the study period, identiﬁcation of mi-
croorganisms and their antibiotic susceptibility were performed
by using standard biochemical reactions, disc diffusion or
microdilution method, and the MicroScan system (Dade
Behring, West Sacramento, CA, USA). Antimicrobial suscepti-
bility was deﬁned according to CLSI criteria [14]. We applied
the deﬁnitions for multidrug-resistant and extensively drug-
resistant microorganisms described by Magiorakos et al. [15].
Bacteraemic OAI were divided into three categories: (i)
septic arthritis, including both episodes of native septic arthritis
and prosthetic joint infections (PJI); (ii) vertebral osteomyelitis,
including cases of infection with or without the presence of
spine arthrodesis; and (iii) non-vertebral or peripheralClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Inosteomyelitis, which included episodes of peripheral osteomy-
elitis (with or without osteosynthesis). OAI were deﬁned by
the presence of bacteraemia, and a concomitant compatible
clinical picture of septic arthritis (inﬂammatory local signs,
macroscopic pus in joint ﬂuid or the presence of sinus tract)
[8,16], vertebral osteomyelitis (back pain, motion limitation,
and/or macroscopic pus through the spine surgery wound) [4],
or peripheral osteomyelitis (inﬂammatory signs and/or pro-
longed sinus drainage) [1]. Computed tomography or magnetic
resonance imaging was performed if deemed appropriate by
clinicians. Microbiology of OAI was always identiﬁed by blood
samples, and in most cases by additional local samples obtained
from the affected joint or bone. In line with the Lanceﬁeld and
Sherman classiﬁcations, Streptococcus species were divided into
two groups: pyogenic species (Streptococcus pyogenes, Strepto-
coccus agalactiae and Streptococcus pneumoniae) and viridans
streptococci (Streptococcus bovis and Streptococcus milleri, along
with the remaining species) [17]. Endocarditis was diagnosed
using Duke criteria [18].
Cases were considered to be nosocomial, healthcare-
acquired or community-acquired according to the deﬁnitions
provided by Friedman et al. [19].Statistical analysisTo assess the epidemiological changes over time, the bacter-
aemic episodes were grouped into ﬁve periods: 1985–91 (P1),
1992–96 (P2), 1997–2001 (P3), 2002–06 (P4) and 2007–11
(P5). According to the total duration of the study (27 years), we
considered 5-year intervals for all periods except for the ﬁrst
one, in which there was the lower number of cases. Incidence
rates (the number of episodes per 100 000 inhabitants per year)
were calculated after estimating the population that attends our
hospital; the distribution of the population for each hospital in
the region of Barcelona is pre-determined according to the area
where they live. Data on this population were obtained from
the public website page of the Ofﬁcial Statistics in Catalonia [20]:
2 991 146 inhabitants (P1), 2 468 378 (P2), 2 740 127 (P3), 3
021 176 (P4) and 3 185 079 (P5). Changes of several charac-
teristics of bacteraemic OAI episodes were also analysed
regarding the age of patients. The Maentel–Haenszel chi-
squared test was used to assess the changing trends in the
absolute number of incidence and in the characteristics of the
episodes of osteoarticular bacteraemia. The changing trends of
continuous parameters over time were studied with the
Jonckheere–Terpstra test. Comparative analyses were per-
formed with chi-squared or Fisher’s test for categorical vari-
ables, and the Mann–Whitney U-test for continuous variables.fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 254.e1–254.e8
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was considered as statistically signiﬁcant.ResultsA total of 32 727 episodes of clinically signiﬁcant bacteraemia
were registered during the period of study. Of these, 601 ep-
isodes (1.8%) had a concomitant OAI. There was an increasing
incidence of bacteraemic OAI in ﬁve periods (P1 to P5), rising
from 2.34 to 5.78 episodes/100 000 inhabitants per year (p
<0.001); this was also the case for the incidence of total bac-
teraemia in these periods, rising from 162 to 238 episodes/100
000 inhabitants per year (p <0.001). The proportion of bac-
teraemic OAI in relation to all bloodstream infections
increased, from 1.45% in P1 to 2.43% in P5 (p <0.001; Fig. 1).
The bacteraemic OAI were considered to be ‘primary’ (456
cases, 76%) or ‘secondary’ (145, 24%). Among the latter, the
most frequent distant foci of infection were vascular catheter-
related infections (n = 49, 8%) and infective endocarditis (n =
42, 7%). The prevalence of nosocomial episodes of bacteraemic
OAI signiﬁcantly increased during the study period, whereas
community-acquired infections diminished (P1 to P5, 18% and
72% to 30% and 45%, respectively; p <0.001). Concurrently, we
observed the progressive appearance of healthcare-associated
episodes (from 10% to 25%; p <0.001).
Table 1 shows the most important characteristics of the
patients with bacteraemic OAI, and the changes observed over
time. Median age increased signiﬁcantly throughout the periodse sac  fo egat necr e
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FIG. 1. Proportion of total bacteraemic cases compared with the total
cases and different types of bacteraemic osteaorticular infections.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectstudied; this was also the case when intravenous drug users
were excluded (data not shown) taking into account that the
rate of this population decreased over time (p <0.001).
Concurrently, we observed an increasing percentage of patients
suffering from comorbid conditions (p <0.001).
Out of 601 cases of bacteraemic OAI, 36 (6%) had multiple
OAI. Overall, septic arthritis was the most frequent (n = 291,
46%), followed by vertebral osteomyelitis (n = 241, 38%) and
peripheral osteomyelitis (n = 105, 16%). Changes over time for
different types of OAI are presented in Table 1. Although the
number of episodes of septic arthritis increased over the
period, its frequency with respect to all OAI signiﬁcantly
decreased (57% in P1 and 38% in P5; p <0.001). The type of
septic arthritis changed between the ﬁrst (P1) and the last (P5)
period of the study, with a lower incidence of native arthritis
and an increase in the number of PJI (p <0.001). Although the
incidence of peripheral osteomyelitis remained stable
throughout the period studied, the number of vertebral oste-
omyelitis increased signiﬁcantly. In fact, the number of all
foreign body-related infections increased from 7% in P1 to 28%
in P5 (p <0.001).Microbiology of bacteraemic OAIGram-positive cocci caused 80% of OAI. The proportion of
polymicrobial and anaerobic OAI was very low (2.4% and 1%,
respectively) (Table 2). Staphylococcus aureus was by far the
most frequent cause of episodes of all types of OAI, whereas
other microorganisms showed more afﬁnity for a particular
infection (Table 3). In comparison with S. aureus, the viridans
streptococci and Enterococcus faecalis groups produced more
vertebral osteomyelitis (56% and 57%, respectively), whereas
pyogenic streptococci species caused septic arthritis (67%).
Among cases of bacteraemic OAI caused by S. aureus, MRSA
strains were more commonly involved in cases of PJI than
methicillin-susceptible S. aureus (MSSA) strains (p <0.05).
Fig. 2 illustrates the increasing incidence of the more
frequent aetiologies in the study period. The number of epi-
sodes of OAI caused by S. aureus increased throughout the
period of study, but its global proportion with respect to other
microorganisms fell from 71% in P1 to 57% in P5 (p 0.1). Sig-
niﬁcant changes were observed in the proportion of episodes
caused by MSSA (a decrease from 71% in P1 to 45% in P5; p
<0.001) and those by MRSA (an increase from 0% to 12%,
respectively; p <0.001). The episodes of OAI caused by Strep-
tococcus sp. and Enterococcus sp. showed a trend towards an
increase (from 10% to 19%; p 0.141). The frequency of Enter-
obacteriaceae and Pseudomonas aeruginosa bacteraemia
remained more stable (17% in P1 and 21% in P5). The numberious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 254.e1–254.e8
TABLE 1. Characteristics of patients and episodes of bacteraemic osteaorticular infections (OAI) and their changes over time
All OAI
n [ 601
Periods of the study
1985–91
n [ 70
1992–96
n [ 70
1997–2001
n [ 97
2002–06
n [ 181
2007–11
n [ 183 p valuea
Age (median, IQR) 63 (50–74) 49 (24–64) 58 (32–68) 64 (50–74) 64 (53–74) 65 (53–77) <0.001
Male 366 (61) 39 (56) 42 (60) 68 (70) 114 (63) 103 (56) 0.2
Underlying diseases
One or more 307 (51) 16 (23) 22 (31) 51 (53) 111 (61) 107 (59) <0.001
Intravenous drug users 57 (10) 17 (24) 9 (13) 13 (13) 11 (6) 7 (4) <0.001
Diabetes mellitus 153 (26) 11 (16) 13 (19) 24 (25) 55 (30) 50 (27) 0.013
Neoplasm 71 (12) 1 (1) 3 (4) 15 (15) 30 (16) 22 (12) 0.006
Cardiopathy 88 (15) 1 (1) 2 (3) 14 (14) 29 (16) 42 (23) <0.001
Chronic renal insufﬁciency 44 (7) 0 2 (3) 5 (5) 17 (9) 20 (11) <0.001
Immunosuppressive therapy 88 (15) 6 (9) 4 (6) 14 (14) 34 (19) 30 (16) 0.01
Reumathoid arthritis 30 (5) 5 (7) 0 7 (7) 10 (6) 8 (4) 0.2
Systemic autoimmune disease 16 (3) 1 (1) 2 (3) 3 (3) 3 (2) 7 (1) 0.4
Type of OAI
Septic arthritisb 291 (46) 41 (57) 37 (49) 50 (49) 88 (45) 75 (38) 0.006
Nativec 228 (78) 37 (90) 32 (86) 40 (80) 70 (79) 49 (65)
Prostheticc 63 (22) 4 (10) 5 (14) 10 (20) 18 (21) 26 (35) 0.001
Vertebral osteomyelitisb 241 (38) 18 (25) 26 (35) 37 (36) 71 (37) 89 (46) 0.001
Nativec 206 (86) 18 (100) 25 (96) 37 (100) 60 (85) 66 (74)
Spine instrumentationc 35 (14) 0 1 (4) 0 11 (15) 23 (26) <0.001
Peripheral osteomyelitisb 105 (16) 13 (18) 12 (16) 15 (15) 34 (18) 31 (16) 0.9
With osteosynthesisc 16 (15) 1 (7) 3 (25) 1 (7) 8 (23) 3 (10) 0.3
Device-related infectionsd 114 (19) 5 (7) 9 (13) 11 (11) 37 (20) 52 (28) <0.001
Data presented as numbers of cases (percentage).
ap value represents the changing trends over periods of the study (Jonckheere–Terpstra test).
bTotal: 637 OAI types in 601 cases of bacteraemic OAI, with 36 cases that presented more than one concurrent infection (6%).
cPercentages of episodes are calculated with respect to total episodes of septic arthritis, vertebral osteomyelitis or peripheral osteomyelitis, respectively.
dDevice-related infections include prosthetic joint infections and osteosynthesis hardware.
CMI Murillo et al. Epidemiology of osteoarticular infection 254.e4of extended-spectrum β-lactamase-producing Enter-
obacteriaceae and multidrug-resistant P. aeruginosa was very low
(two and three episodes, respectively), but they increased in
the last two periods (from none in the three ﬁrst periods to
two cases in P4 and three cases in P5; p 0.082).Characteristics of bacteraemic OAI
regarding the age of patientsTable 4 shows the main characteristics of episodes of OAI and
the differences between age groups (group 1, patients aged 49
or less, group 2, patients aged 50 to 64, and group 3, patients
aged 65 or over).
In comparison with younger patients (group 1), patients in
groups 2 and 3 had more underlying diseases, and OAI were
more frequently hospital-acquired or healthcare-related. Pe-
ripheral osteomyelitis was more frequent in the younger pa-
tients, whereas there were more episodes of vertebral
osteomyelitis in groups 2 and 3 (p <0.05). There were no dif-
ferences in the total number of episodes of arthritis, but older
patients (groups 2 and 3) had signiﬁcantly more PJI.
Regarding microbiology, S. aureus was involved in a greater
number of episodes of OAI in younger patients than in the
older ones (p 0.002); when these staphylococcal OAI
occurred, MSSA strains were responsible for almost all epi-
sodes in group 1, whereas MRSA strains were signiﬁcantly
more frequent in patients in groups 2 and 3. Streptococcal
infections (either pyogenic or viridans species) increased inClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Inolder patients, and enterococcal OAI were signiﬁcantly related
with the oldest patients (group 3). OAI caused by Gram-
negative bacilli were less common among younger patients
(group 1).
The main differences between groups 2 and 3 were that the
oldest group presented signiﬁcantly less native arthritis and
more PJI, and a higher frequency of enterococcal infections.
Additionally, we compared the median age of patients with
bacteraemic OAI during the study period by types of infection
and microbiology (see Supporting information, Table S1). Of
note, median age of all septic arthritis signiﬁcantly increased
from 48 years in P1 to 68 years in P5 (p 0.001); this was mainly
due to the rise in the number of PJI cases, which occurred in an
older population that did not signiﬁcantly change over time. In a
similar way, a signiﬁcant increase in the age of patients was
observed for staphylococcal OAI, this being related to the rise
in the number of episodes caused by MRSA strains in older
patients. All of these differences were maintained when young
population of intravenous drug users were excluded. In
contrast, no signiﬁcant changes in the median age of patients
over time were observed for episodes of vertebral osteomye-
litis and for episodes of OAI caused by other relevant
microorganisms.DiscussionThe present study shows the progressive rise in the number of
patients with OAI and bacteraemia, this being the cause or thefectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 254.e1–254.e8
TABLE 2. Microbiology of the 601 episodes of bacteraemic
osteoarticular infections
Gram-positive microorganisms 492 (80%)
Staphylococcus spp. 386 (62%)
S. aureusa 368 (59%)
Coagulase-negative staphylococci 18 (3%)
Streptococcus spp. 86 (17%)
S. pneumoniae 14 (2%)
S. pyogenes 12 (2%)
S. agalactiae 23 (4%)
S. group anginosus 7 (1%)
S. bovisb 7 (1%)
Other group viridans streptococci c 15 (2%)
Other Streptococcus spp. d 8 (1%)
Enterococcus spp. 15 (2%)
E. faecalis 14 (2%)
E. faecium 1 (0.2%)
Other Gram-positive microorganisms e 5 (0.8%) 5 (0.8%)
Gram-negative microorganisms 126 (20%)
Enterobacteriaceae 87 (14%)
Escherichia coli 58 (9%)
Klebsiella pneumoniae 8 (1%)
Proteus mirabilis 8 (1%)
Salmonella enteritidis 5 (0.8%)
Morganella morgani 3 (0.4%)
Enterobacter cloacae 2 (0.3%)
Citrobacter spp 2 (0.3%)
Serratia marcescens 1 (0.2%)
Non-fermenting Gram-negative bacilli 13 (2%)
Pseudomonas aeruginosa 11 (2%)
Aeromonas hydrophila 1 (0.2%)
Acinetobacter baumanii 1 (0.2%)
Other Gram-negative microorganisms 18 (3%)
Neisseria meningitidis 8 (1%)
Haemophilus spp 4 (0.6%)
Veillonella spp 2 (0.3%)
Eikenella corrodens 2 (0.3%)
Kingella kingae 1 (0.2%)
Campylobacter sp. 1 (0.2%)
Anaerobic Gram-negative microorganisms 8 (1%)
Bacteroides spp. 7 (1%)
Porphyromonas sp. 1 (0.2%)
Total: 618 isolates in 601 episodes of bacteraemic osteoarticular infections, with 15
episodes (2.4%) of polymicrobial bacteraemia. Microbiology of polymicrobial
infections: S. aureus + S. agalactiae (2); S. aureus + Streptococcus group G, S. aureus +
P. mirabilis (2); S. aureus + E. coli; E. faecalis + coagulase-negative staphylococci
(CoNS); E. faecalis + E. coli; E. faecalis + A. baumanii; K. pneumoniae + CoNS;
K. pneumoniae + P. aeruginosa; E. coli + P. aeruginosa; E. corrodens + CoNS;
P. mirabilis + S. intermedius; C. glabrata + CoNS.
aThis included 49 isolates (13%) of methicillin-resistant S. aureus.
bS. bovis type I (5 isolates) and S. bovis type II (2 isolates).
cS. sanguis (6 isolates), S. mitis (6 isolates), S. mutans (2 isolates) and S. salivarius (1
isolates).
dS. equi group C (3 isolates), β-haemolyticus Streptococcus of group G (4 isolates)
and β-haemolyticus Streptococcus of group F (1 isolate).
eAbiotroﬁa sp (1 isolate), Aerococcus viridans (1 isolate), Corynebacterium sp (1 isolate),
Eubacterium lentum (1 isolate) and Arcanobacterium sp (1 isolate).
254.e5 Clinical Microbiology and Infection, Volume 21 Number 3, March 2015 CMIconsequence of osteoarticular infection itself, and describes the
trends observed in our area during the last three decades. Our
study shows the signiﬁcant rise in the number of all types of
OAI over a long period (three decades), as has previously been
reported for the particular case of vertebral osteomyelitis [1,6].
These increased rates of OAI have been associated with
longer life expectancy and the development of chronic diseases
[1,6,21]. In agreement with previous reports, we observed a
signiﬁcant increase in the age of patients with OAI. Previous
studies highlighted an association between OAI and patients
with intravenous drug abuse, who are usually younger
[3,22,23]. Our results suggest that this harmful social habit has
been progressively abandoned, and that it no longer has an
effect on the current pattern of bacteraemic OAI.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectGiven the increase in life expectancy, the higher prevalence
of chronic diseases observed in our patients may be aging-
related. In addition, modern medical advances have generated
new technologies that can be offered to a high number of older
patients [24]. We observed a progressive increase in the
number of episodes of OAI related with orthopaedic devices. It
is known that the implantation and revision of joint prostheses
have risen signiﬁcantly [7,25], which implies an increase in the
absolute number of episodes of infection [8,24]. Our results
agree with these reports, and included not just joint prostheses
but osteosynthesis hardware as well. In fact, the current pattern
of bacteraemic OAI has been modiﬁed by the impact of these
foreign material-associated infections, which represented 28%
of all infections in the most recent period. Although the inci-
dence of PJI and osteosynthesis-related infections all rose,
among ‘native’ OAI vertebral osteomyelitis was the only one to
record an increase. Interestingly, due to the increase of older
patients, the pattern of non-device-related OAI has also
changed. While the presence of septic arthritis did not differ
between patients of different ages, peripheral osteomyelitis was
predominant among patients under 50 years of age and verte-
bral osteomyelitis was more frequent in older patients. Overall,
the pattern of OAI in younger patients reﬂected the predom-
inance of native arthritis and peripheral osteomyelitis, whereas
older patients had more PJI and vertebral osteomyelitis.
Accordingly, the increase in the median age of patients
observed in some OAI (i.e. septic arthritis) was mainly related
to the rise in the number of episodes that occurred in older
patients (i.e. PJI).
Finally, regarding these epidemiological changes, the source
and acquisition of OAI has also changed. We observed a pro-
gressive increase in nosocomial episodes, the emergence of
healthcare-related infections, and a decrease in the number of
strictly community-acquired OAI. These results seem to agree
with recent works in other ﬁelds which reﬂect the improve-
ments obtained with modern medical and social assistance
[11,19,26].
Staphylococcus aureus is recognized as the most important
aetiology of OAI [1,2,5], as was the case in the present study,
but we noted a progressive decline in its proportion with
respect to other microorganisms. Moreover, the pattern of
these infections has clearly changed with a signiﬁcant emer-
gence of MRSA, mostly among older patients, and a decrease in
MSSA infections. The presence of Streptococcus and Enterococcus
species is also notable and, together with staphylococcal epi-
sodes, highlights the major role of gram-positive cocci in this
setting. Our results emphasize the greater presence of S. aureus
in young patients (75% of OAI, MSSA strains in almost all cases)
than in older patients (56–58%, with the emergence of MRSA
strains), this being related with the increased age of patientsious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 254.e1–254.e8
TABLE 3. Differences between more frequent microorganisms and their type of osteoarticular infections caused
Arthritis Vertebral osteomyelitis Peripheral osteomyelitis (POM)
All Native Prosthetic All Native Spine All DM Foot POM-no OS OS
Staphylococcus aureus (n = 384) 182 (47) 141 (36) 41 (11) 131 (35) 109 (29) 22 (6) 71 (18) 16 (4) 42 (11) 13 (3)
MSSA (n = 333)a 156 (47) 126 (38) 30 (9) 120 (36) 100 (30) 20 (6) 57 (17) 11 (3) 35 (11) 11 (3)
MRSA (n = 51) 26 (51) 15 (29) 11 (22) 11 (22) 9 (19) 2 (3) 14 (27) 5 (10) 7 (14) 2 (3)
pyogenic streptococci (n = 57)b 38 (67) 32 (56) 6 (11) 15 (26) 15 (26) 0 4 (7) 3 (5) 1 (2) 0
viridans streptococci (n = 41)c 12 (29) 10 (24) 2 (5) 23 (56) 22 (54) 1 (2) 6 (15) 0 6 (15) 0
Enterococcus (n = 14)d 5 (36) 3 (22) 2 (14) 8 (57) 7 (50) 1 (7) 1 (7) 0 0 1 (7)
GNB (n = 118)e 44 (37) 34 (28) 10 (9) 51 (44) 40 (35) 11 (9) 23 (19) 11 (9) 10 (8) 2 (2)
Note: Data presented are number of cases (percentage); cases with multiple OAI (n = 36) are included.
Abbreviations: POM, peripheral osteomyelitis; DM foot, diabetic foot infections; POM-no OS, peripheral osteomyelitis without osteosynthesis; OS, osteosynthesis; MSSA,
methicillin-susceptible S. aureus; MRSA, methicillin-resistant S. aureus; pyogenic streptococci, Streptococcus pyogenes, Streptococcus agalactiae and Streptococcus pneumoniae; GNB,
Gram-negative bacilli.
aDifferences between MSSA and MRSA, p 0.03 (chi-square)
bDifferences between S. aureus (All) and pyogenic streptococci (All), p 0.02 (chi-square)
cDifferences between S. aureus (All) and viridans streptococci (All), p 0.02 (chi-square)
dNo signiﬁcant differences between S. aureus (All) and Enterococcus sp. (All)
eNo signiﬁcant differences between S. aureus (All) and GNB (All).
CMI Murillo et al. Epidemiology of osteoarticular infection 254.e6with staphylococcal OAI observed over time; and also, our
results show the predominance of streptococcal and entero-
coccal OAI in the group of older patients. Finally, these changes
in the Gram-positive microbiology of OAI may also be associ-
ated with the differences in the types of OAI observed over
time. Hence, our results support the higher afﬁnity of viridans
streptococci and Enterococcus species for causing vertebral
osteomyelitis, or that of pyogenic streptococcus strains for
causing arthritis. These results seem to corroborate those of
previous authors [27–29], but further studies addressing this
speciﬁc ﬁeld are required to conﬁrm them.
Regarding the world-wide emergence of multidrug-resistant
Gram-negative bacilli [30,31], we have witnessed only(a)
FIG. 2. Incidence of the more frequent microorganisms responsible for bac
cases caused by methicillin-susceptible and -resistant Staphylococcus aureus. (
Gram-negative bacilli.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Inanecdotal episodes in the last 10 years. These data are sur-
prising because drug-resistant Gram-negative bacterial in-
fections, including bacteraemia, have been described in our
country and elsewhere [30,32]. It is beyond the scope of our
work to identify why these microorganisms did not cause OAI,
but we may hypothesize that they will emerge in the future. In
addition, we note that the low rate of polymicrobial and
anaerobic OAI of our work should be interpreted taken into
account that we included only bacteraemic infections and so,
both entities can be underestimated.
The present study has some limitations that are inherent to
observational studies, but in any case it offers a global
perspective of a great number of OAI over a long period of(b)
teraemic osteaorticular infections in the study period. (a) Incidence of
b) Incidence of cases caused by Streptococcus sp., Enterococcus sp. and
fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 254.e1–254.e8
TABLE 4. Clinical and microbiological characteristics of cases of osteoarticular infections according to patients’ age: Group 1 (age
£ 49 years), Group 2 (age 50–64 years), and Group 3 (age ‡ 65 years)
Group 1
n [ 149
Group 2
n [ 178 p value (1 vs 2)
Group 3
n [ 274 p value (2 vs 3) p value (1 vs 3)
One or more underlying disease 24 (16) 106 (60) <0.001 177 (65) 0.3 <0.001
Intravenous drug users 56 (38) 1 (1) <0.001 0 0.2 <0.001
Place of acquisition
Community 108 (72) 92 (52) 134 (49)
Health-care 10 (7) 35 (20) 54 (20)
Nosocomial 31 (21) 51 (29) <0.001 85 (31) 0.8 <0.001
Device-related OAIa 19 (13) 26 (15) 0.6 68 (25) 0.009 0.003
Arthritis 76 (51) 82 (46) 0.3 133 (48) 0.6 0.6
Native 74 (50) 72 (40) 0.09 82 (30) 0.02 <0.001
Prosthetic 2 (1) 10 (6) 0.04 51 (18) <0.001 <0.001
Vertebral osteomyelitis 37 (25) 66 (37) 0.02 102 (37) 0.9 0.01
Spine instrumentation 9 (6) 16 (9) 0.3 10 (4) 0.02 0.2
Peripheral osteomyelitis 37 (25) 27 (15) 0.03 40 (15) 0.9 0.009
Staphylococcus aureus 111 (75) 104 (58) 0.002 153 (56) 0.6 <0.001
methicillin-susceptible S. aureus 108 (73) 90 (50) <0.001 120 (44) 0.2 <0.001
methicillin-resistant S. aureus 3 (2) 14 (8) 0.02 32 (12) 0.2 0.001
Pyogenic streptococci 8 (5) 13 (7) 0.4 28 (10) 0.3 0.09
Viridans streptococci 3 (2) 16 (9) 0.007 20 (7) 0.5 0.02
Enterococcus sp. 2 (1) 1 (1) 0.4 12 (4) 0.02 0.09
Gram-negative bacilli 20 (13) 39 (22) 0.047 53 (19) 0.5 0.1
aDevice-related OAI include infections of prosthetic joint, spine instrumentation and osteomyelitis with osteo-synthesis hardware.
254.e7 Clinical Microbiology and Infection, Volume 21 Number 3, March 2015 CMItime. It should be noted that our study refers only to the
incidence of bacteraemic OAI and we do not know the overall
incidence of OAI, including bacteraemic and non-bacteraemic
cases; therefore in the present report the incidence of overall
OAI has been underestimated. Indeed, the increased incidence
of bacteraemic OAI in our study could be due to either a
greater number of patients with OAI or to a higher prevalence
of bacteraemia among patients with OAI.
In conclusion, we have observed an increased number of
bacteraemic OAI over the last three decades in the setting of an
aging population with more chronic diseases. Cases associated
with orthopaedic devices have increased, and the rates of
nosocomially acquired and healthcare-related cases have also
risen. Staphylococcus aureus remains the most frequent cause of
OAI, but we stress the emergence of infections by MRSA and
the increase of streptococcal and enterococcal episodes.
Overall, these signiﬁcant epidemiological changes reﬂect the
pattern of development of OAI for the early twenty-ﬁrst cen-
tury, which is likely to involve older patients with several
comorbidities, particular types of OAI, and speciﬁc microor-
ganisms with a predominance of multidrug-resistant bacteria.Transparency declarationThe authors declare that they have no conﬂicts of interest.AcknowledgementsThis work was supported by Ministerio de Economía y Com-
petitividad, Instituto de Salud Carlos III—co-ﬁnanced byClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectEuropean Development Regional Fund ‘A way to achieve
Europe’ ERDF, Spanish Network for the Research in Infectious
Diseases (REIPI RD12/0015).
It was presented in part at the 23rd European Congress of
Clinical Microbiology and Infectious Diseases, Berlin 27–30
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